Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2015101724575N1Phase 3Completed
Phase 3 trial of trivalent influenza vaccine in influenza (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Post-vaccination immunogenicity. Started Feb 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2015101724575N1.